Opaleye Management Inc. Q4 2018 Filing
Filed February 14, 2019
Portfolio Value
$268.0M
Holdings
47
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (47 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CDXSCODEXIS INC | 1,750,000 | $29.2M | 10.91% | |
| 2 | AXGNAXOGEN INC | 1,300,000 | $26.6M | 9.91% | |
| 3 | —LOXO ONCOLOGY INC | 175,000 | $24.5M | 9.15% | |
| 4 | AMRNAMARIN CORP PLC | 1,250,000 | $17.0M | 6.35% | |
| 5 | 2L9BLUEPRINT MEDICINES CORP | 300,000 | $16.2M | 6.04% | |
| 6 | —IMPRIMIS PHARMACEUTICALS INC | 1,722,000 | $9.8M | 3.66% | |
| 7 | FGENEURFIBROGEN INC | 200,000 | $9.3M | 3.45% | |
| 8 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 340,000 | $7.1M | 2.66% | |
| 9 | —EPIZYME INC | 1,125,000 | $6.9M | 2.59% | |
| 10 | PTCTPTC THERAPEUTICS INC | 190,000 | $6.5M | 2.43% | |
| 11 | XNCRXENCOR INC | 180,000 | $6.5M | 2.43% | |
| 12 | VKTXVIKING THERAPEUTICS INC | 825,000 | $6.3M | 2.36% | |
| 13 | —STRONGBRIDGE BIOPHARMA PLC | 1,390,000 | $6.2M | 2.32% | |
| 14 | —CERECOR INC | 2,185,536 | $6.2M | 2.32% | |
| 15 | FRXFENNEC PHARMACEUTICALS INC | 900,000 | $5.7M | 2.14% | |
| 16 | GBYSANGAMO BIOSCIENCES INC | 500,000 | $5.7M | 2.14% | |
| 17 | CBAYUSDCYMABAY THERAPEUTICS INC | 725,000 | $5.7M | 2.13% | |
| 18 | —POLARITYTE INC | 400,000 | $5.4M | 2.01% | |
| 19 | —AUDENTES THERAPEUTICS INC | 250,000 | $5.3M | 1.99% | |
| 20 | CMRXEURCHIMERIX INC | 2,020,000 | $5.2M | 1.94% | |
| 21 | XOMAXOMA CORP DEL | 400,000 | $5.1M | 1.89% | |
| 22 | IMGNEURIMMUNOGEN INC | 1,021,000 | $4.9M | 1.83% | |
| 23 | APLSAPELLIS PHARMACEUTICALS INC | 275,000 | $3.6M | 1.35% | |
| 24 | —AIMMUNE THERAPEUTICS INC | 150,000 | $3.6M | 1.34% | |
| 25 | —ABEONA THERAPEUTICS INC | 450,000 | $3.2M | 1.20% | |
| 26 | ETONETON PHARMACEUTICALS INC | 523,000 | $3.2M | 1.19% | |
| 27 | ACADACADIA PHARMACEUTICALS INC | 195,000 | $3.2M | 1.18% | |
| 28 | 1T7TRICIDA INC | 123,000 | $2.9M | 1.08% | |
| 29 | —MAGENTA THERAPEUTICS INC | 505,000 | $2.9M | 1.07% | |
| 30 | —CIDARA THERAPEUTICS INC | 1,200,000 | $2.8M | 1.05% | |
| 31 | —AVENUE THERAPEUTICS INC | 496,000 | $2.7M | 1.00% | |
| 32 | TGTXTG THERAPEUTICS INC | 550,000 | $2.3M | 0.84% | |
| 33 | PBYIPUMA BIOTECHNOLOGY INC | 100,000 | $2.0M | 0.76% | |
| 34 | —EIDOS THERAPEUTICS INC | 140,000 | $1.9M | 0.72% | |
| 35 | MGNXMACROGENICS INC | 150,000 | $1.9M | 0.71% | |
| 36 | —CLEMENTIA PHARMACEUTICALS INC | 150,000 | $1.8M | 0.66% | |
| 37 | —ZYMEWORKS INC | 105,000 | $1.5M | 0.58% | |
| 38 | COLLCOLLEGIUM PHARMACEUTICALS INC | 80,000 | $1.4M | 0.51% | |
| 39 | —MIRAGEN THERAPEUTICS INC | 385,000 | $1.2M | 0.44% | |
| 40 | CTIC1USDCTI BIOPHARMA CORP | 1,400,000 | $1.0M | 0.38% | |
| 41 | —PROTALIX BIOTHERAPEUTICS INC | 2,500,000 | $777K | 0.29% | |
| 42 | —ODONATE THERAPEUTICS INC | 49,000 | $690K | 0.26% | |
| 43 | —AXOVANT SCIENCES | 580,000 | $577K | 0.22% | |
| 44 | —DERMIRA INC | 75,000 | $539K | 0.20% | |
| 45 | —ASSERTIO THERAPEUTICS INC | 120,000 | $433K | 0.16% | |
| 46 | —ARDELYX INC | 200,000 | $358K | 0.13% | |
| 47 | —BIOLINERX LTD | 250,000 | $109K | 0.04% |